|
|
| Phases of Development | Pilot | Phase I/II | Phase II | Phase III | Registration | Approved | Marketed |
|---|
| Autoimmune | 0 | 0 | 0 | 0 | 1 | 1 | 2 | | Cancer | 0 | 0 | 0 | 1 | 0 | 0 | 0 | | Cardiovascular | 0 | 1 | 0 | 0 | 0 | 1 | 4 | | Dermatology | 0 | 0 | 0 | 0 | 0 | 0 | 2 | | Genitourinary | 1 | 0 | 0 | 0 | 0 | 0 | 0 | | Ophthalmic | 0 | 0 | 0 | 0 | 1 | 0 | 0 | | Pulmonary | 0 | 0 | 0 | 1 | 0 | 0 | 0 | | Renal | 0 | 0 | 0 | 1 | 0 | 0 | 0 | | Transplant | 0 | 0 | 1 | 0 | 1 | 2 | 4 |
|
|

Products Targeting FK506 binding protein (macrophilin-12)